Phyllis Camp, 64, was proactive about her health. The Saltillo, Miss. social worker tried reducing stress, she ate healthy, and visited her local physician regularly.
But even the most health conscious can’t change their family history. And Camp’s family history includes heart disease.
In December 2012 Camp made history when she received Abbott’s Absorb stent as part of the investigational study ABSORB III. She was the first person in the U.S. to receive the device.
Today, we’re sharing her story following the Food and Drug Administration’s (FDA's) approval of Absorb, the world’s first fully dissolving heart stent.
Common diagnosis, traditional, treatment
Camp’s story begins in December 2010 when she had a heart attack more than a decade after being diagnosed with coronary artery disease. This is the most common type of heart disease in the U.S., affecting 15 million people.
To open Camp’s blocked arteries, her doctor implanted two permanent metallic stents.
Following several weeks of recovery she resumed her normal activities. Camp returned to work full-time, began caring for her elderly mom, and regularly saw her cardiologist.
What doctors didn’t know at the time was that Camp has a special type of cholesterol that absorbs rapidly and contributes to her heart condition but doesn’t show up as abnormal on blood tests.
Fast forward to 2012.
During a routine cardiology appointment, Camp told her doctor she’d been feeling chest pain. The physician did some tests and found that Camp needed another stent to open a blocked artery.
This time, however, instead of implanting another traditional metallic stent, interventional cardiologist Dr. Barry Bertolet at North Mississippi Medical Center, suggested something new — our Absorb stent.
Unlike traditional metal stents, which are permanent implants, Absorb is made of a naturally dissolvable material. It dissolves completely within approximately three years, once it has done its job of keeping a clogged artery open and promoting healing of the artery.1
The doctor “explained to me that I would be the first person in the United States to receive this,” said Camp. “I thought, if Dr. Bertolet says it’s OK, well, it’s OK. Let’s do this thing.”
And so in December 2012, Camp made history. She became the first person in the U.S. to receive Absorb as part of the ABSORB III investigational study.
Since the procedure, Camp has been enjoying life. “I can work in my flower garden and I go to work,” she said. “I have been blessed to have the life I have.”
Watch this video to learn more about Phyllis Camp.
On July 5, 2015, the FDA approved Absorb, which is an important step in providing new options to people with heart disease in the U.S.
The innovative device is available in more than 100 countries, including the U.S. And it’s the only fully dissolving stent approved by the FDA for the treatment of coronary artery disease.
Click here to learn more about the FDA approval of Absorb.
The Absorb GT1 Bioresorbable Vascular Scaffold (BVS) is a temporary scaffold that will fully resorb over time and is indicated for improving coronary luminal diameter in patients with ischemic heart disease due to de novo native coronary artery lesions (length ≤ 24 mm) with a reference vessel diameter of ≥ 2.5 mm and ≤ 3.75 mm.
See Important Safety Information here.
1. Absorb dissolves except for two pairs of tiny metallic markers that remain in the artery to enable a physician to see where the device was placed.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.